1 Supplementary Information Figure S1 . Side by side comparison Ub synthesis using two or six dipeptide analogues and HCTU or PyBOP as coupling agent. The Ub peptide sequences were synthesized in parallel on 25 μmol scale starting with Fmoc-Gly Trityl resin. Fmoc deprotection was performed 3x using 20% piperidine in NMP (1x5 min., 1x10 min., 1x5 min.), followed by washing the resin 6x with NMP. Coupling of Fmoc-protected amino acids was achieved by adding a pre-activated mixture to the resin of 4 equiv. of Fmoc-protected amino acid, 4 equiv. of PyBOP or HCTU and 8 equiv. of DIPEA. After 45 min. the resin was washed 3x with NMP. Coupling of pseudoproline building blocks on positions Leu8-Thr9, Ile13-Thr14, Leu56-Ser57 and Ser65-Thr66, and dimethoxybenzyl (Dmb) dipeptides on positions Ala46-Gly47 and Asp52-Gly53, was extended to two hours. In the comperative syntheses using only two dipeptide analogues, a pseudoproline building block was used on position Leu56-Ser57 and a Dmb dipeptide was introduced on position Asp52-Gly53. After the last cycle, resin was washed 4x with diethyl ether (Et 2 O) and dried at high vacuum. To cleave the Ub from the resin a mixture of TFA, phenol, triisopropylsilane (TIPS) and water (90:2.5:2.5:5) was added to the resin and shaken for three hours. The resin was filtered and the filtrate was precipitated in cold Et 2 O:n-pentane (3:1). The precipitate was isolated by centrifugation for 6 min. at 1500 g at 4˚C and washed by 3 repetitive cycles of resuspension in ice-cold Et 2 O and centrifugation. Finally, the pellet was taken up in water:acetonitrole:acetic acid (65:25:10), frozen and lyophilized. We analyzed the products by analytical S3-S7) . The additional peaks shown in the LC spectra of the UbVME probes originate from an impurity on the column, as this peak is also shown when a blank is run (lowest panel). Figure S14. Fluorescent DUB activity probe 2 allows for direct comparison of differential activity profiles.
Androgen receptor (AR) signalling is important in all stages of prostate cancer and androgen deprivation through chemical castration or use of anti-androgens are frequently used in therapy. We examined DUB activity in the LNCaP derivatives, LNCaP-AI (androgen independent) and LNCaP-CdxR that were continuously cultured in androgen depleted conditions or in the presence of the anti-androgen Casodex (CAS), respectively, that are representative of advanced prostate cancer. We also manipulated androgen levels in LNCaP cells using the androgen receptor agonist dihydrotesterone (DHT) or androgen antagonist Casodex to examine the response to AR transcriptional activation or inhibition. DUB activity profiles were examined by treating lysates with 2. For the different conditions tested, no UCHL1 activity was observed. These data suggest UCHL1 activity is independent of AR status.
Experimental section Figure S14
LNCaP cells were grown in RPMI 1640 medium (Gibco) supplemented with 10% (v/v) fetal calf serum (FCS) and 2 mM L-glutamine at 37 ˚C in 5% CO 2 atmosphere. LNCaP-CdxR cells were generated and maintained continuously in 2 μM Casodex, as described previously.** LNCaP-AI cells were generated in house by serially maintaining 12 Figure S15 . The presence of labeled and unlabeled UCHL in DU145 cell extract was confirmed using UCHL1 antibody. DU145 cell extract (2 mg/mL) was incubated with 1 μM probe 4 as described in the methods section.
Following SDS-PAGE analysis, proteins were blotted onto PVDF membrane and stained with anti-UCH-L1 (Enzo Life Sciences) (dilution 1:2000) and Swine Anti-Rabbit HRP (Dako) (dilution 1:10000) as secondary antibody.
Proteins were visualized as described in the methods section. UCHL1 was present in DU145 cell extracts as shown by anti-UCHL1 staining. The UCHL1 band migrated at the same molecular weight as the abundant fluorescent DUB present in DU145 cell extract.
